Co-Authors
This is a "connection" page, showing publications co-authored by ANIL K SOOD and VAHID AFSHAR-KHARGHAN.
Connection Strength
3.073
-
Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles. Mol Cancer Ther. 2022 07 05; 21(7):1067-1075.
Score: 0.218
-
Platelets Increase the Expression of PD-L1 in Ovarian Cancer. Cancers (Basel). 2022 May 19; 14(10).
Score: 0.216
-
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. Cancers (Basel). 2022 Mar 15; 14(6).
Score: 0.213
-
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective. Cancer Metastasis Rev. 2022 03; 41(1):147-172.
Score: 0.211
-
The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell. 2018 06 11; 33(6):965-983.
Score: 0.163
-
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017 08 21; 8(1):310.
Score: 0.156
-
Role of ADP receptors on platelets in the growth of ovarian cancer. Blood. 2017 09 07; 130(10):1235-1242.
Score: 0.154
-
Role of Platelet-Derived Tgf?1 in the Progression of Ovarian Cancer. Clin Cancer Res. 2017 Sep 15; 23(18):5611-5621.
Score: 0.154
-
A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets. 2017 Jan; 28(1):99-102.
Score: 0.145
-
Lipid profile of platelets and platelet-derived microparticles in ovarian cancer. BBA Clin. 2016 Dec; 6:76-81.
Score: 0.144
-
Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 2016 Nov; 27(7):716-718.
Score: 0.142
-
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest. 2016 05 02; 126(5):1885-96.
Score: 0.142
-
Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition. J Immunol. 2016 Feb 01; 196(3):1412-8.
Score: 0.139
-
Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res. 2015 Feb 01; 21(3):602-10.
Score: 0.129
-
Platelet effects on ovarian cancer. Semin Oncol. 2014 Jun; 41(3):378-84.
Score: 0.123
-
Autocrine effects of tumor-derived complement. Cell Rep. 2014 Mar 27; 6(6):1085-1095.
Score: 0.122
-
Platelets increase the proliferation of ovarian cancer cells. Blood. 2012 Dec 06; 120(24):4869-72.
Score: 0.110
-
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012 Feb 16; 366(7):610-8.
Score: 0.106
-
Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer. J Thromb Haemost. 2022 01; 20(1):104-114.
Score: 0.052
-
Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer. Sci Adv. 2021 07; 7(30).
Score: 0.051
-
The Provocative Roles of Platelets in Liver Disease and Cancer. Front Oncol. 2021; 11:643815.
Score: 0.051
-
The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer. Blood Adv. 2021 04 13; 5(7):1947-1951.
Score: 0.050
-
OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancer. Blood Adv. 2020 07 28; 4(14):3329-3342.
Score: 0.048
-
Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer. Proc Natl Acad Sci U S A. 2015 Nov 17; 112(46):14266-71.
Score: 0.034